Clinical Trials Browser

Phase 1 × Breast Neoplasms, Male × Flow Cytometry × Clear all

NCT01219907 2013-05-17

Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer

Phase 1 Withdrawn

Breast Neoplasms, Breast Neoplasms, Male